Gene A, a gene increased by mutant KRAS, is a potentially druggable target for lung adenocarcinoma

被引：0

作者：

Umeda, Kanna ^{[1
]}

Kawabe, Nozomi ^{[1
]}

Muraki, Nao ^{[1
]}

Komeda, Kazuki ^{[2
]}

Ohashi, Ayano ^{[1
]}

Katsuda, Masahito ^{[1
]}

Tomatsu, Aya ^{[1
]}

Yoshida, Mikina ^{[1
]}

Minna, John ^{[3
,4
]}

Tanaka, Ichidai ^{[2
]}

Morise, Masahiro ^{[2
]}

Matsushima, Miyoko ^{[1
]}

Kawabe, Tsutomu ^{[1
]}

Sato, Mitsuo ^{[1
]}

机构：

[1] Nagoya Univ, Div Host Def Sci, Dept Integrated Hlth Sci, Grad Sch Med, Nagoya, Aichi, Japan

[2] Nagoya Univ, Dept Resp Med, Grad Sch Med, Nagoya, Aichi, Japan

[3] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA

[4] Univ Texas Southwestern Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA

来源：

RESPIROLOGY | 2024年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

AP04-003

引用

页码：91 / 91

页数：1

共 50 条

[31] Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients
Falk, Alexander T.
Yazbeck, Nathalie
Guibert, Nicolas
Chamorey, Emmanuel
Paquet, Agnes
Ribeyre, Lydia
Bence, Coraline
Zahaf, Katia
Leroy, Sylvie
Marquette, Charles-Hugo
Cohen, Charlotte
Mograbi, Baharia
Mazieres, Julien
Hofman, Veronique
Brest, Patrick
Hofman, Paul
Ilie, Marius
LUNG CANCER, 2018, 121 : 70 - 75
[32] Increased mutant KRAS gene dosage drives pancreatic cancer progression: evidence for wild-type KRAS as a tumor suppressor?
Kent, Oliver A.
HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (05) : 403 - 405
[33] A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers
Guerra, Stephanie L.
Maertens, Ophelia
Kuzmickas, Ryan
De Raedt, Thomas
Adeyemi, Richard O.
Guild, Caroline J.
Guillemette, Shawna
Redig, Amanda J.
Chambers, Emily S.
Xu, Man
Tiv, Hong
Santagata, Sandro
Janne, Pasi A.
Elledge, Stephen J.
Cichowski, Karen
CANCER CELL, 2020, 37 (05) : 705 - +
[34] In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma
Li, Fei
Huang, Qingyuan
Luster, Troy A.
Hu, Hai
Zhang, Hua
Ng, Wai-Lung
Khodadadi-Jamayran, Alireza
Wang, Wei
Chen, Ting
Deng, Jiehui
Ranieri, Michela
Fang, Zhaoyuan
Pyon, Val
Dowling, Catriona M.
Bagdatlioglu, Ece
Almonte, Christina
Labbe, Kristen
Silver, Heather
Rabin, Alexandra R.
Jani, Kandarp
Tsirigos, Aristotelis
Papagiannakopoulos, Thales
Hammerman, Peter S.
Velcheti, Vamsidhar
Freeman, Gordon J.
Qi, Jun
Miller, George
Wong, Kwok-Kin
CANCER DISCOVERY, 2020, 10 (02) : 270 - 287
[35] Coexistence of two missense mutations in the KRAS gene in adenocarcinoma of the lung: a possible indicator of poor prognosis
Spinelli, Manuela
Du Parcq, Persephone
Gupta, Nandita
Khorashad, Jamshid
Viola, Patrizia
PATHOLOGICA, 2022, 114 (03) : 221 - 227
[36] Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma
Shibata, Tatsuhiro
Hanada, Satoko
Kokubu, Akiko
Matsuno, Yoshihiro
Asamura, Hisao
Ohta, Tsutomu
Sakamoto, Michiie
Hirohashi, Setsuo
CANCER SCIENCE, 2007, 98 (07): : 985 - 991
[37] XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
Jimi Kim
Elizabeth McMillan
Hyun Seok Kim
Niranjan Venkateswaran
Gurbani Makkar
Jaime Rodriguez-Canales
Pamela Villalobos
Jasper Edgar Neggers
Saurabh Mendiratta
Shuguang Wei
Yosef Landesman
William Senapedis
Erkan Baloglu
Chi-Wan B. Chow
Robin E. Frink
Boning Gao
Michael Roth
John D. Minna
Dirk Daelemans
Ignacio I. Wistuba
Bruce A. Posner
Pier Paolo Scaglioni
Michael A. White
Nature, 2016, 538 : 114 - 117
[38] XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
Kim, Jimi
McMillan, Elizabeth
Kim, Hyun Seok
Venkateswaran, Niranjan
Makkar, Gurbani
Rodriguez-Canales, Jaime
Villalobos, Pamela
Neggers, Jasper Edgar
Mendiratta, Saurabh
Wei, Shuguang
Landesman, Yosef
Senapedis, William
Baloglu, Erkan
Chow, Chi-Wan B.
Frink, Robin E.
Gao, Boning
Roth, Michael
Minna, John D.
Daelemans, Dirk
Wistuba, Ignacio I.
Posner, Bruce A.
Scaglioni, Pier Paolo
White, Michael A.
NATURE, 2016, 538 (7623) : 114 - +
[39] ΔFOSB: A Potentially Druggable Master Orchestrator of Activity-Dependent Gene Expression
Robison, Alfred J.
Nestler, Eric J.
ACS CHEMICAL NEUROSCIENCE, 2022, 13 (03): : 296 - 307
[40] Fatty Acid Synthase Is a Therapeutic Target in Mutant KRAS Lung Cancer
Bartolacci, C.
Padanad, M.
Andreani, C.
Melegari, M.
Rindhe, S.
George, K.
Frankel, A.
McDonald, J.
Scaglioni, P. P.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1538 - S1538

← 1 2 3 4 5 →